Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
Wenxiang, Liaoning, China Related Funds
| Fund Name | Location |
| ARM Labs | Abuja, Federal Capital Territory, Nigeria |
| Beringer Capital | Canada, Ontario, Toronto |
| Blockchain Investment Group | New York, New York, United States |
| BridgeBio | California, Palo Alto, United States |
| Ether Capital | Beijing, Beijing, China |
| Evli Growth Partners | Finland, Helsinki, Southern Finland |
| FPT Group | - |
| GGM Capital | Canton Luxembourg, Luxembourg, Münsbach |
| Grupo Alta | Costa Rica, San José, San Jose Province |
| Haowo Konggu Jituan | China, Jinan, Shandong |
| Health Insight Capital | Nashville, Tennessee, United States |
| Matomy | Israel, Tel Aviv, Tel Aviv District |
| Nanjing Xiaofan Wangluo Keji Youxian Gongsi | China, Jiangsu, Nanjing |
| North Coast Opportunities Technology Fund | Cleveland, Ohio, United States |
| SEA Ventures | Pennsylvania, Pittsburgh, United States |
| Seven Peaks Ventures | Bend, Oregon, United States |
| Taiya Dingfu | China, Fujian, Xiamen |
| w2solution | Japan, Tokyo |
| Zhixing Venture Capital | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Pneuma Respiratory | $10M | 14 Aug 2018 | Boone, North Carolina, United States | ||
Laminate Medical | $8M | 08 Feb 2017 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
| 24 Nov 2016 | Qingyang District, Sichuan, China | ||||
Regentis Biomaterials | $15M | 07 Feb 2016 | Israel, North District, Israel | ||
EndoSpan | $10M | 26 Oct 2015 | Israel, Tel Aviv District, Israel | ||
MST Medical Surgery Technologies | $12M | 01 Jul 2015 | Israel, North District, Israel |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
